An EcN strain with a hypoxia-inducible promoter and genes related to the synthesis of stimulator-of-interferon-gene (STING) agonists was designed to activate APC specifically in tumor sites (Fig. 4a, b) [66]. Here, STING1 is linked to neoplasm.